Brad L. Schoenfeld

KO client Seasats, a maritime startup, recently announced that it has accepted a strategic investment from L3Harris Technologies, a global aerospace and defense technology innovator. With the investment, Seasat’s autonomous ocean vehicles will partner with L3Harris products to create innovative maritime solutions for customers in the commercial and defense sectors.…

KO’s article published on June 27, 2022 highlighted Colorado’s crackdown on most non-compete restrictions. HB 22-1317 has now been codified as CRS 8-2-113 and became effective on August 10, 2022. This new law effectively renders unenforceable most post-employment non-competes and other restrictive covenants, including customer non-solicitation restrictions, for Colorado residents.…

In March, when the Colorado General Assembly added a key provision to Colorado’s non-compete statute that put those knowingly out of compliance at risk of criminal charges and fines, it created a buzz among business leaders and employment law experts. Now, a new bill (HB 22-1317) passed by the Colorado…

The real business implications of Colorado’s “new” non-compete legislation Recent updates to Colorado’s non-compete statute have created a buzz among business leaders and employment law experts. Through SB 21-271, the Colorado General Assembly, as of March 1, 2022, added a key provision to Colorado’s non-compete statute, C.R.S. § 8-2-113 (the…

Koenig, Oelsner, Taylor, Schoenfeld & Gaddis PC (KO Law Firm) has named Jon Taylor as the firm’s new Managing Partner. In his new role, Jon will help guide KO’s strategic vision and oversee the firm’s day-to-day operations. He will also continue to serve clients, as part of his corporate transactional law practice.…

Imagine stepping away from your job for two full months, with full pay and benefits, while all your work is covered by your team. That’s sixty days with no Zoom meetings, calls or emails – and it’s something that’s hard to imagine for most people. That’s because most professionals have…

Sydnexis, Inc., a clinical stage biopharmaceutical company, has completed a $45 million Series B financing led by Visionary Ventures, Blue Stem Capital, and SC Master Fund. The KO team, led by partners Kevin Gibson and Brad Schoenfeld, represented Sydnexis. The company sees progressive myopia (nearsightedness) in children as a “significant…

VitriVax, the developer of a novel stabilization and delivery platform for vaccines and therapeutics, has closed its first institutional financing round with Adjuvant Capital. KO partners Jon Taylor and Brad Schoenfeld, and attorney Matt Burns represented VitriVax in the financing round. The Series A proceeds will be used to develop…